Abstract
Background and Aim: Gastrin is one of the most important gut hormones. However, the role of the gastrin-gastrin receptor (GR) system in the growth of gastric tumors is still unclear. Methods: We examined serum gastrin levels in 957 patients with early gastric carcinoma. Next, we raised antibody against the GR and examined GR expression in 5 gastric carcinoma cell lines and 48 human gastric tumor tissues. In 28 cases, Helicobacter pylori eradication therapy was performed and morphological tumor changes were examined. Results: Serum gastrin levels were significantly higher in patients with elevated tumors than in patients with depressed tumors (p = 0.02). All gastric carcinoma cell lines expressed GR. Thirty-one of 48 (65%) gastric tumors expressed GR, and its expression was prominent in elevated-type tumor with an intestinal histologic feature. Of 28 patients who underwent eradication therapy, 9 showed gastric tumors that became flat or depressed. In these 9 cases, GR expression was detected in all tumors, and the decrease in gastrin levels was more prominent than in those without morphological change (p = 0.01). Conclusion: The gastrin-GR system plays an important role in the elevated morphology of gastric tumors.
Journal Section:
Original Paper
References
1.
Watson SA, Grabowska AM, El-Zaatari M, Takhar A: Gastrin – active participant or bystander in gastric carcinogenesis? Nat Rev Cancer 2006;12:936–946.
2.
Naito Y, Ito M, Watanabe T, Suzuki H: Biomarkers in patients with gastric inflammation: a systematic review. Digestion 2005;72:164–180.
[PubMed]
3.
Sumiyoshi H, Yasui W, Ochiai A, Tahara E: Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice. Cancer Res 1984;44:4276–4280.
[PubMed]
4.
Ochiai A, Yasui W, Tahara E: Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res1985;76:1064–1071.
[PubMed]
5.
McWilliams DF, Watson SA, Crosbee DM, Michaeli D, Seth R: Coexpression of gastrin and gastrin receptors (CCK-B and δCCK-B) in gastrointestinal tumour cell lines. Gut 1998;42:795–798.
[PubMed]
6.
Watson SA, Clarke PA, Morris TM, Caplin ME: Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor. Cancer Res 2000;60:5902–5907.
[PubMed]
7.
Lee YM, Beinborn M, McBride EW, Lu M, Kolakowski LF Jr, Kopin AS: The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem 1993;268:8164–8169.
[PubMed]
8.
Kumamoto T, Sumii K, Haruma K, Tari A, Tanaka K, Kajiyama G: Gastrin receptors in the human gastrointestinal tract and pancreas. Gastroenterol Jpn 1989;24:109–114.
[PubMed]
9.
Kazumori H, Ishihara S, Kawashima K, Fukuda R, Chiba T, Kinoshita Y: Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection. FEBS Lett 2001;489:208–214.
[PubMed]
10.
Schmitz F, Göke MN, Otte JM, Schrader H, Reimann B, Kruse ML, Siegel EG, Peters J, Herzig KH, Fölsch UR, Schmidt WE: Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa. Regul Pept 2001;102:101–110.
[PubMed]
11.
Kulaksiz H, Arnold R, Goke B, Maronde E, Meyer M, Fahrenholz F, Forssmann WG, Eissele R: Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach. Cell Tissue Res 2000;299:289–298.
[PubMed]
12.
Henwood M, Clarke PA, Smith AM, Watson SA: Expression of gastrin in developing gastric adenocarcinoma. Br J Surg 2001;88:564–568.
[PubMed]
13.
Suzuki H, Hibi T, Marshall BJ: Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007;42:1–15.
[PubMed]
14.
Ito M, Tanaka S, Kamada T, Haruma K, Chayama K: Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis. World J Gastroenterol 2006;12:10–16.
[PubMed]
15.
Chiba T, Seno H, Marusawa H, Wakatsuki Y, Okazaki K: Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol 2006;41: 1–9.
[PubMed]
16.
Ito M, Tanaka S, Takata S, Oka S, Imagawa S, Ueda H, Egi Y, Kitadai Y, Yasui W, Yoshihara M, Haruma K, Chayama K: Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther 2005;21:559–566.
[PubMed]
17.
Ito M, Tanaka S, Kim S, Tahara K, Kawamura Y, Sumii M, Takehara Y, Hayashi K, Okamoto E, Kunihiro M, Kunita T, Imagawa S, Takata S, Ueda H, Egi Y, Hiyama T, Ueno Y, Kitadai Y, Yoshihara M, Chayama K: A combination of the Helicobacter pylori stool antigen test and urea breath test is useful for clinical evaluation of eradication therapy: a multicenter study. J Gastroenterol Hepatol 2005;20:1241–1245.
[PubMed]
18.
Haruma K, Yoshihara M, Sumii K, Tari A, Watanabe C, Kodoi A, Kajiyama G: Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma. Scand J Gastroenterol 1993;28:633–637.
[PubMed]
19.
Ito M, Tanaka S, Kim S, Kuwai T, Matsutani N, Kamada T, Kitadai Y, Sumii M, Yoshihara M, Haruma K, Chayama K: The specific expression of hypoxia inducible factor-1α in human gastric mucosa induced by nonsteroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2003;18(suppl 1):90–98.
[PubMed]
20.
Hur K, Kwak MK, Lee HJ, Park DJ, Lee HK, Lee HS, Kim WH, Michaeli D, Yang HK: Expression of gastrin and its receptor in human gastric cancer tissues. J Cancer Res Clin Oncol 2006;132:85–91.
[PubMed]
21.
Helander HF, Wong H, Poorkhalkali N, Walsh JH: Immunohistochemical localization of gastrin/CCK-B receptors in the dog and guinea-pig stomach. Acta Physiol Scand 1997;159:313–320.
[PubMed]
22.
Tommeras K, Hammer P, Sundler F, Borch K, Mardh S, Cabero JL: Immunolocalization of cholecystokinin-2 receptors in rat gastric mucosa. Scand J Gastroenterol 2002;37:1017–1024.
[PubMed]
23.
Yang CH, Ford J, Karelina Y, Shulkes A, Xiao SD, Baldwin GS: Identification of a 70-kDa gastrin-binding protein on DLD-1 human colorectal carcinoma cells. Int J Biochem Cell Biol 2001;33:1071–1079.
[PubMed]
24.
Watson SA, Clarke PA, Smith AM, Varro A, Michaeli D, Grimes S, Caplin M, Hardcastle JD: Expression of CCKB/gastrin receptor isoforms in gastro-intestinal tumour cells. Int J Cancer 1998;77:572–577.
[PubMed]
25.
Watson SA, Morris TM, Varro A, Michaeli D, Smith AM: A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth. Gut 1999;45:812–817.
[PubMed]
26.
Mürköster S, Isberner A, Arlt A, Witt M, Reimann B, Blaszczuk E, Werbing V, Fölsch UR, Schmitz F, Schäfer H: Gastrin suppresses growth of CCK2 receptor expressing colon cancer cells by inducing apoptosis in vitro and in vivo. Gastroenterology 2005;129:952–968.
[PubMed]
27.
Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ, Fox JG: Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36–47.
[PubMed]
28.
Takaishi S, Cui G, Frederick DM, Carlson JE, Houghton J, Varro A, Dockray GJ, Ge Z, Whary MT, Rogers AB, Fox JG, Wang TC: Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology 2005;128:1965–1983.
[PubMed]
29.
Fukui T, Nishio A, Okazaki K, Uza N, Ueno S, Kido M, Inoue S, Kitamura H, Kiriya K, Ohashi S, Asada M, Tamaki H, Matsuura M, Kawasaki K, Suzuki K, Uchida K, Fukui H, Nakase H, Watanabe N, Chiba T: Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice. Gut 2006;55:607–615.
[PubMed]
30.
Friis-Hansen L, Rieneck K, Nilsson HO, Wadstrom T, Rehfeld JF: Gastric inflammation, metaplasia, and tumor development in gastrin-deficient mice. Gastroenterology 2006;131:246–258.
[PubMed]
© 2008 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2008
You do not currently have access to this content.
